Vascular oxidative stress is associated with insulin resistance in hyper-reninemic nonmodulating essential hypertension

Journal of Hypertension

Volumn 25, Issue 12, 2007, Pages 2434-2440

  Sanchez, Ramiro ^a,c   Fischer, Patricia ^b   Cuniberti, Luis ^b   Masnatta, Lucas D ^b   Ramírez, Agustín J ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^b Universidad Rene G Favaloro   (Argentina)

^c Sección Hipertensión Arterial Y Unidad Metabólica   (Argentina)

Author keywords

Essential hypertension; Insulin resistance; Nitric oxide bioactivity; Nonmodulation; Oxidative stress

Indexed keywords

3 NITROTYROSINE; ARGININE; CYCLIC GMP; ISOPROSTANE; NITRATE; NITRITE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; GLUCOSE TOLERANCE TEST; HIGH SODIUM INTAKE; HOMEOSTASIS; HUMAN; HYPERRENINEMIA; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; KIDNEY BLOOD FLOW; OXIDATIVE STRESS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINALYSIS;

EID: 35948970654     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f03597     Document Type: Article

References (38)

1. Williams GH, Hollenberg NK. Nonmodulating hypertension. A subset of sodium-sensitive hypertension. Hypertension 1991; 17 (Suppl I):81-85.
2. Moore TJ, Williams GH, Dluhy RG, Bavli SZ, Hinathongkan T, Greenfield M. Altered renin-angiotensin-aldosterone relationships in normal renin essential hypertension. Circ Res 1977; 41:167-171.
3. Sanchez R, Nolly H, Giannone C, Baglivo HP, Ramírez AJ. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension. J Hypertens 2003; 21:411-418.
4. Gaboury CL, Hollenberg NK, Hopkins PN, Williams R, Williams GH. Metabolic derangements in nonmodulating hypertension. Am J Hypertens 1995; 8:870-875.
5. Sanchez RA, Ramos F, Giannone C, Fischer P, Masnatta L, Baglivo HP, et al. Parallel renal and extremity blood supply abnormalities in nonmodulation: responses to ACE inhibition. Hypertension 2003; 41:919-924.
6. Luscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 1987; 9:157-163.
7. Zhou MS, Schulman IH, Raij L. Nitric oxide, angiotensin II and hypertension. Semin Nephrol 2004; 24:366-378.
8. Szentivanyi M, Zou AP, Mattson DL, Soares P, Moreno C, Roman RJ, Cowley AW. Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 2002; 283:R266-R272.
9. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002; 90:E58-E65.
10. Schnurr E, Lahma W, Kuppers H. Measurements of renal clearence of inulin and PAH in the steady-state without urine collection. Clin Nephrol 1980; 13:26-29.
11. Sánchez R, Giménez MI, Migliorini M, Giannone C, Ramírez AJ, Weder AB. Erythrocyte sodium-lithium countertransport in nonmodulating offspring and essential hypertensive individuals: response to enalapril. Hypertension 1997; 30:99-105.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
13. Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE, Darracott Vaughan E Jr. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med 1972; 52:633-652.
14. Kim SW, Lee J, Paek YW, Kang DG, Choi KC. Decreased nitric oxide synthesis in rats with chronic renal failure. J Korean Med Sci 2000; 15:425-430.
15. Lowry OH, Rosebroughn NJ, Farr AL, Randall RJ. Protein determination with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
16. Pradelles P, Grassi J, Chabardes D, Guiso N. Enzyme immunoassay of adenosine cyclic 3′,5′-monophosphate and guanosine cyclic 3′,5′-monophosphate using acetylcholinesterase. Ann Chem 1989; 61:447-453.
17. Vaziri ND, Linag K, Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead induced hypertension. Kidney Int 1999; 56:1492-1498.
18. Roberts LJ II, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28:505-513.
19. Sanchez R, Gimenez MI, Ramos F, Baglivo H, Ram?rez AJ. Nonmodulating hypertension: evidence for the involvement of kallikrein/kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long term Na restriction. J Hypertens 1996; 14:1287-1291.
20. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001; 37:541-546.
21. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002; 346:1954-1962.
22. Dzau VJ. Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001; 37:1047-1052.
23. Griedling KK, Ollerenshaw JD, Minicri CA, Alexander RW. Angiotensin II stimulates NADH and NADPH activity in cultured vascular smooth muscle cells. Circ Res 1994; 74:1141-1148.
24. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 1996; 97:1916-1923.
25. Rubangy GM, Vanhoutte PM. Superoxide and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 1986; 250:H822-H827.
26. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Griedling KK, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95:588-593.
27. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens 2001; 10:247-255.
28. McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension: the role of superoxide anion. Hypertension 1999; 34:539-545.
29. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJV, Dominiczak AF. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000; 101:2206-2212.
30. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1993; 21:660-666.
31. Matsuoka H, Itoh S, Kimoto M, Kohno K, Tamai O, Wada Y, et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 1997; 29:242-247.
32. Perticone F, Sciacqua A, Perticone M, Maas R, Boger RH, et al. Assymetric dimethylarginine, L-arginine and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 2005; 46:518-523.
33. Paiva H, Laakso J, Laine H, Laaksonen R, Knuuti J, Raitakari OT. Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia. J Am Coll Cardiol 2002; 40:I241-I247.
34. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, et al. Reduced urinary excretion of nitric oxide metabolites and increased levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 1999; 33:652-658.
35. Goonasekera CD, Rees DD, Woolard P, Frend A, Shah V, Dillon MJ. Nitric oxide synthase inhibitors and hypertension in children and adolescents. J Hypertens 1997; 15:901-909.
36. Fujiwara N, Osanai T, Kamada T, Katch T, Takahashi K, Okumara K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation 2000; 101:856-861.
37. Luparini RL, Ferri C, Santucci A, Balsano F. Atrial natriuretic peptide in nonmodulating essential hypertension. Hypertension 1993; 21:803-809.
38. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 2002; 282:R335-R342.